Multicenter stage Two demo (SWOG S1609, cohort Fifty one) involving ipilimumab and nivolumab in metastatic or even unresectable angiosarcoma: a new substudy of twin anti-CTLA-4 as well as anti-PD-1 blockade within unusual tumors (DART).

Due to terms of use violation, your account has been suspended by Akismet Anti-Spam Plugin.

lentilkayak28 64 days ago News Discuss

Due to terms of use violation, your account has been suspended by Akismet Anti-Spam Plugin. #